Elevance Health Inc. (ELV) Tops Q1 EPS by $1.74, Beats on Revenue; Offers FY26 EPS Guidance

Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $12.58, $1.74 better than the analyst estimate of $10.84. Revenue for the quarter came in at $49.5 billion versus the consensus estimate of $48.2 billion.

GUIDANCE:

Elevance Health Inc. sees FY2026 EPS of $26.75, versus the consensus of $25.75.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Trump says North Korea's Kim responded to his outreach